U.S. markets close in 1 hour 14 minutes

F-star Therapeutics, Inc. (FSTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.44-0.05 (-0.82%)
As of 2:45PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/2/2021
Current
3/31/2021
Market Cap (intraday) 5
100.70M98.56M
Enterprise Value 3
101.38M83.19M
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
3.692.54
Price/Book (mrq)
2.892.29
Enterprise Value/Revenue 3
7.9128.52
Enterprise Value/EBITDA 7
-3.78-7.82

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3260.53%
S&P500 52-Week Change 332.68%
52 Week High 315.50
52 Week Low 30.97
50-Day Moving Average 37.49
200-Day Moving Average 38.70

Share Statistics

Avg Vol (3 month) 3203.42k
Avg Vol (10 day) 3143.35k
Shares Outstanding 519.37M
Implied Shares Outstanding 6N/A
Float 12.43M
% Held by Insiders 11.33%
% Held by Institutions 139.90%
Shares Short (Jul 14, 2021) 4178.43k
Short Ratio (Jul 14, 2021) 41.2
Short % of Float (Jul 14, 2021) 40.92%
Short % of Shares Outstanding (Jul 14, 2021) 40.92%
Shares Short (prior month Jun 14, 2021) 463.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 22, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin -221.01%
Operating Margin (ttm)-185.13%

Management Effectiveness

Return on Assets (ttm)-25.73%
Return on Equity (ttm)-130.62%

Income Statement

Revenue (ttm)12.82M
Revenue Per Share (ttm)1.41
Quarterly Revenue Growth (yoy)115.30%
Gross Profit (ttm)11.26M
EBITDA -22.62M
Net Income Avi to Common (ttm)-28.33M
Diluted EPS (ttm)-3.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.68M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)4.35M
Total Debt/Equity (mrq)12.50
Current Ratio (mrq)0.96
Book Value Per Share (mrq)3.83

Cash Flow Statement

Operating Cash Flow (ttm)-29.08M
Levered Free Cash Flow (ttm)N/A